- Brand name:
- Pharmaceutical Company:
- Condition/Indication: Pneumococcal disease
- Meeting Date: November 2022
- Public Summary Document (PSD) November 2022 PBAC Meeting - (PDF 1.1KB)
- Public Summary Document (PSD) November 2022 PBAC Meeting - (Word 253KB)
Pneumococcal Polysaccharide Conjugate Vaccine – November 2022
Pneumococcal Polysaccharide Conjugate Vaccine, 20-Valent Adsorbed: 0.5 mL pre-filled syringe; Prevenar 20®
Last updated
8 July 2025